Latest Financial Performance News

CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.

Cash Converters has expanded its Australian footprint by acquiring 14 franchise stores across key states, reinforcing its strategy to grow earnings and consumer lending.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

Ariadne Australia Limited anticipates a near breakeven total comprehensive income for FY25, balancing solid profits with significant portfolio losses and partnership costs.

Wrkr Limited is raising approximately A$15 million through an institutional placement to accelerate growth amid upcoming Payday Super reforms and market opportunities.

Rewardle Holdings Limited reported a 2.8% revenue increase to $9.68 million for FY24 but swung to a $3.44 million net loss, driven by rising expenses and associate losses. The company expanded its footprint with acquisitions in grocery delivery and fintech, while deepening its stake in AI-powered health tech partner CloudHolter.

COSOL Limited reports FY25 revenue and EBITDA below guidance due to timing delays but highlights a 17% rise in operating cash flow and maintains optimistic FY26 growth forecasts.

Piedmont Lithium reported strong Q2 2025 operational results with record production at North American Lithium and $11.9 million revenue, while shareholder voting on its merger with Sayona Mining has been adjourned to August 11.

AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.

Novo Resources Corp. reported key drilling milestones at its Pilbara and New South Wales projects in Q2 2025, alongside a reduced net loss and ongoing liquidity challenges. The company’s exploration momentum continues despite material uncertainty over its going concern status.

Novo Resources Corp reported a reduced net loss of CAD 5.85 million for H1 2025, improving liquidity while continuing its gold exploration efforts in Australia.